自体组织子宫悬吊术与子宫切除术治疗盆腔器官脱垂的长期结局比较
本回顾性队列研究基于TriNetX网络数据,比较自体组织子宫悬吊术与子宫切除术(均行顶端悬吊)治疗顶端盆腔器官脱垂的长期再治疗结局。倾向性评分匹配后,子宫悬吊术组长期脱垂再手术风险及总体再治疗率均高于子宫切除术组,但短期尿潴留和尿路感染发生率略低。
要点
- 子宫悬吊术组长期脱垂再手术风险高于子宫切除术组(11.1% vs 6.5%,HR 1.77)。
- 子宫悬吊术组总体脱垂再治疗率高于子宫切除术组(15.0% vs 9.6%,HR 1.63)。
- 子宫悬吊术组短期尿潴留和尿路感染发生率略低于子宫切除术组。
核心结论
- 与子宫切除术相比,自体组织子宫悬吊术长期脱垂再治疗风险略高,但短期术后并发症略低。
研究设计与样本
- 回顾性队列研究,纳入2005年11月1日至2025年11月1日期间在TriNetX网络美国医疗组织中接受自体组织顶端脱垂修复的女性。
- 比较子宫保留手术(子宫悬吊术)与子宫切除术(均行宫骶韧带悬吊或骶棘韧带固定),并进行倾向性评分匹配。
- 长期结局分析纳入2015年11月1日前手术的女性,长期随访队列包含子宫切除术组2499例和子宫悬吊术组876例,中位随访分别为9.1年和8.7年。
主要发现
- 子宫悬吊术组长期随访中26例(2.9%)后续行子宫切除术。
- 匹配队列中,子宫悬吊术组脱垂再手术率为11.1%,子宫切除术组为6.5%(HR 1.77,95% CI 1.27-2.45)。
- 匹配队列中,子宫悬吊术组总体脱垂再治疗率为15.0%,子宫切除术组为9.6%(HR 1.63,95% CI 1.24-2.14)。
- 匹配队列短期分析中,子宫悬吊术组尿潴留发生率8.5%,子宫切除术组10.9%(HR 0.78,95% CI 0.70-0.87)。
- 匹配队列短期分析中,子宫悬吊术组尿路感染发生率6.5%,子宫切除术组8.2%(HR 0.79,95% CI 0.70-0.90)。
临床怎么用
- 临床决策需权衡子宫悬吊术较低的短期并发症与较高的长期脱垂再治疗风险。
- 对于选择子宫悬吊术的患者,应告知其长期再手术或 pessary 使用的可能性较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare long-term retreatment outcomes after native tissue hysteropexy and hysterectomy with apical suspension for apical pelvic organ prolapse. METHODS: This retrospective cohort study included women undergoing native tissue apical prolapse repair between November 1, 2005, and November 1, 2025, in U.S. health care organizations included in the TriNetX research network. Women were classified as having either uterine-preserving surgery (hysteropexy) or hysterectomy, both with concomitant apical suspension using either uterosacral ligament suspension or sacrospinous ligament fixation. Propensity score matching was performed to balance baseline demographic, clinical, and procedural characteristics. Short-term outcomes included postoperative complications occurring within 30 days of surgery. Long-term outcomes were assessed in women undergoing surgery before November 1, 2015. The primary outcome was prolapse retreatment , defined as reoperation or pessary use occurring 30 days or more after the index procedure. Time-to-event analyses were conducted with Cox proportional hazards models, with results reported as hazard ratios (HRs) and 95% CIs. RESULTS: The long-term follow-up cohort included 2,499 women in the hysterectomy group and 876 women in the hysteropexy group, with a median follow-up of 9.1 and 8.7 years, respectively. Among women undergoing hysteropexy, subsequent hysterectomy occurred in 26 patients (2.9%) during long-term follow-up. In the matched cohorts, hysteropexy was associated with a higher risk of prolapse reoperation compared with hysterectomy (11.1% vs 6.5%, HR 1.77, 95% CI, 1.27-2.45) and a higher overall prolapse retreatment rate (15.0% vs 9.6%, HR 1.63, 95% CI, 1.24-2.14). In short-term analyses, hysteropexy was associated with lower rates of urinary retention (8.5% vs 10.9%, HR 0.78, 95% CI, 0.70-0.87) and urinary tract infection (6.5% vs 8.2%, HR 0.79, 95% CI, 0.70-0.90) compared with hysterectomy in the matched cohorts. CONCLUSION: Native tissue hysteropexy is associated with a modestly higher long-term risk of prolapse retreatment compared with hysterectomy while demonstrating slightly lower rates of short-term postoperative complications.
引用
- Akavian I, Reuveni-Salzman A, Zilberman T, et al. Long-Term Outcomes After Native Tissue Hysteropexy Compared With Hysterectomy for Treatment of Pelvic Organ Prolapse. Obstet Gynecol. 2026. PMID: 42424621. doi:10.1097/AOG.0000000000006371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。